Summary
Lexaria Bioscience (LEXX) Recent Earnings
Lexaria Bioscience (LEXX) reported a 2nd Quarter February 2026 loss of $0.06 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.10 per share on revenue of $0.1 million. Revenue fell 88.5% compared to the same quarter a year ago.
Results
Reported Earnings
($0.06)
Earnings Whisper
-
Consensus Estimate
($0.10)
Reported Revenue
$0.0 Mil
Revenue Estimate
$0.1 Mil
Growth
Earnings Growth
Revenue Growth
Earnings Release
